SYROS PHARMACEUTICALS, INC. Revenues
SYROS PHARMACEUTICALS, INC. reported Revenues of $3.83 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-11-05
- SYROS PHARMACEUTICALS, INC. revenues for the quarter ending 2020-09-30 was $3.83M, a 586.02% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. revenues for the quarter ending 2020-06-30 was $3.19M, a 590.04% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. revenues for the quarter ending 2020-03-31 was $2.38M, a 424.01% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. revenues for the quarter ending 2019-12-31 was $508.00K, a 43.11% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. revenues for fiscal 2019 was $1.98M, a 3.32% decline from fiscal 2018.
- SYROS PHARMACEUTICALS, INC. revenues for fiscal 2018 was $2.05M, a 86.19% increase from fiscal 2017.
- SYROS PHARMACEUTICALS, INC. revenues for fiscal 2017 was $1.10M, a 247.32% increase from fiscal 2016.
- SYROS PHARMACEUTICALS, INC. revenues for fiscal 2016 was $317.00K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-09-30 | $3.83M 10-Q · filed 2020-11-05 | $7.02M derived: sum of 2 quarters · filed 2020-11-05 | $9.39M 10-Q · filed 2020-11-05 | $9.90M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $3.19M 10-Q · filed 2020-08-06 | $5.57M 10-Q · filed 2020-08-06 | $6.08M derived: sum of 3 quarters · filed 2020-08-06 | $6.63M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-03-31 | $2.38M 10-Q · filed 2020-05-07 | $2.89M derived: sum of 2 quarters · filed 2020-05-07 | $3.44M derived: sum of 3 quarters · filed 2020-11-05 | $3.91M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-12-31 | $508.00K 10-K · filed 2020-03-05 | $1.07M derived: sum of 2 quarters · filed 2020-11-05 | $1.53M derived: sum of 3 quarters · filed 2020-11-05 | $1.98M 10-K · filed 2020-03-05 |
| 2019-09-30 | $558.00K 10-Q · filed 2020-11-05 | $1.02M derived: sum of 2 quarters · filed 2020-11-05 | $1.47M 10-Q · filed 2020-11-05 | $2.37M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $462.00K 10-Q · filed 2020-08-06 | $916.00K 10-Q · filed 2020-08-06 | $1.81M derived: sum of 3 quarters · filed 2020-08-06 | $2.22M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $454.00K 10-Q · filed 2020-05-07 | $1.35M derived: sum of 2 quarters · filed 2020-05-07 | $1.76M derived: sum of 3 quarters · filed 2020-05-07 | $2.13M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $893.00K 10-K · filed 2020-03-05 | $1.30M derived: sum of 2 quarters · filed 2020-03-05 | $1.68M derived: sum of 3 quarters · filed 2020-03-05 | $2.05M 10-K · filed 2020-03-05 |
| 2018-09-30 | $412.00K 10-K · filed 2020-03-05 | $787.00K derived: sum of 2 quarters · filed 2020-03-05 | $1.16M 10-Q · filed 2019-11-12 | $1.16M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $375.00K 10-K · filed 2020-03-05 | $745.00K 10-Q · filed 2019-08-01 | $745.00K derived: sum of 3 quarters · filed 2020-03-05 | $745.00K derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $370.00K 10-K · filed 2020-03-05 | $370.00K derived: sum of 2 quarters · filed 2020-03-05 | $370.00K derived: sum of 3 quarters · filed 2020-03-05 | $370.00K derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $0.00 derived: sum of 3 quarters · filed 2020-03-05 | $1.10M 10-K · filed 2020-03-05 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $1.10M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-K 3 month · filed 2018-08-07 | $1.10M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $1.10M 10-K · filed 2019-03-07 | |||
| 2016-12-31 | $317.00K 10-K · filed 2019-03-07 |